Insider Trading Alert - OMI, AVB And JNPR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 7, 2014, 153 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $776.50 to $183,196,515.00.

Highlighted Stocks Traded by Insiders:

Owens & Minor (OMI) - FREE Research Report

Van Sumeren Mark A, who is SVP, Strategy & Business Devel at Owens & Minor, sold 1,800 shares at $32.54 on May 7, 2014. Following this transaction, the SVP, Strategy & Business Devel owned 23,598 shares meaning that the stake was reduced by 7.09% with the 1,800-share transaction.

The shares most recently traded at $33.17, up $0.63, or 1.9% since the insider transaction. Historical insider transactions for Owens & Minor go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 745
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 745
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 47,985

The average volume for Owens & Minor has been 505,300 shares per day over the past 30 days. Owens & Minor has a market cap of $2.1 billion and is part of the services sector and wholesale industry. Shares are down 11.35% year-to-date as of the close of trading on Wednesday.

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare logistics company. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices. The stock currently has a dividend yield of 3.07%. The company has a P/E ratio of 18.5. Currently, there are no analysts who rate Owens & Minor a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OMI - FREE

TheStreet Quant Ratings rates Owens & Minor as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Owens & Minor Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AvalonBay Communities (AVB) - FREE Research Report

Schulman Edward M, who is EVP-General Counsel at AvalonBay Communities, sold 2,634 shares at $137.47 on May 7, 2014. Following this transaction, the EVP-General Counsel owned 14,310 shares meaning that the stake was reduced by 15.55% with the 2,634-share transaction.

The shares most recently traded at $139.56, up $2.09, or 1.5% since the insider transaction. Historical insider transactions for AvalonBay Communities go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 10,130
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 12,988
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 13,805

The average volume for AvalonBay Communities has been 832,200 shares per day over the past 30 days. AvalonBay Communities has a market cap of $17.8 billion and is part of the financial sector and real estate industry. Shares are up 17.66% year-to-date as of the close of trading on Wednesday.

AvalonBay Communities, Inc. engages in the development, redevelopment, acquisition, ownership, and operation of multifamily communities in the United States. The stock currently has a dividend yield of 3.37%. The company has a P/E ratio of 99.7. Currently, there are 8 analysts who rate AvalonBay Communities a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AVB - FREE

TheStreet Quant Ratings rates AvalonBay Communities as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full AvalonBay Communities Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Juniper Networks (JNPR) - FREE Research Report

Sindhu Pradeep, who is Evp Cto at Juniper Networks, sold 55,000 shares at $24.72 on May 7, 2014. Following this transaction, the Evp Cto owned 2.3 million shares meaning that the stake was reduced by 2.31% with the 55,000-share transaction.

The shares most recently traded at $24.96, up $0.24, or 0.95% since the insider transaction. Historical insider transactions for Juniper Networks go as follows:

  • 4-Week # shares sold: 2,595
  • 12-Week # shares sold: 4,782
  • 24-Week # shares sold: 84,545

The average volume for Juniper Networks has been 7.9 million shares per day over the past 30 days. Juniper Networks has a market cap of $11.6 billion and is part of the technology sector and computer hardware industry. Shares are up 9.3% year-to-date as of the close of trading on Wednesday.

Juniper Networks, Inc. designs, develops, and sells products and services for high-performance networks worldwide. The company operates in two segments, Platform Systems Division and Software Solutions Division. The company has a P/E ratio of 27.3. Currently, there are 13 analysts who rate Juniper Networks a buy, no analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JNPR - FREE

TheStreet Quant Ratings rates Juniper Networks as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Juniper Networks Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
null

If you liked this article you might like

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

OMI - Calling All Traders

OMI - Calling All Traders

Insider Trading Alert - OMI, SBY And BRS Traded By Insiders

Insider Trading Alert - OMI, SBY And BRS Traded By Insiders

Insider Trading Alert - KODK, MOS And OMI Traded By Insiders

Insider Trading Alert - KODK, MOS And OMI Traded By Insiders

Insider Trading Alert - PAGP, ARLP And OMI Traded By Insiders

Insider Trading Alert - PAGP, ARLP And OMI Traded By Insiders